Early Venous Stent Failure Predicted by Platelet Count and Neutrophil/Lymphocyte Ratio

Younes Jahangiri, Masayuki Endo, Ramsey Al-Hakim, John Kaufman, Khashayar Farsad

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Inflammation and platelet activation have been shown to be involved in acute thromobogenicity following venous occlusive conditions. The aim of this study was to identify the association of baseline platelet count and neutrophil/lymphocyte ratio (NLR) with venous stent failure. Methods and Results: Patients who underwent technically successful iliocaval venous stent placement with available baseline complete blood count and follow-up stent patency data were selected (n=50). Stent failure was defined as >50% stenosis or occlusion at follow-up angiography, contrast-enhanced CT, MRI or duplex US. Median patient age was 49.5 years (range, 13-76 years), and 62% were female. Median follow-up time was 10.2 months (range, 0.1-76.4 months). Stent failure occurred in 13 patients (26%) after a median of 1.2 months (range, 1 day-76.4 months). On multivariable-adjusted Cox modeling, baseline platelets (HR, 2.28; P=0.004) and WBC count (HR, 2.03; P=0.013) were significantly associated with stent failure on follow-up; neutrophils (HR, 16.10; P=0.050); and NLR (HR, 12.19; P=0.050) had borderline significance. Compared with patients without stent failure, those with early, but not late, stent failure had higher baseline platelets (P=0.031) and neutrophils (P=0.025), and NLR (P=0.026). CONCLUSIONS: Baseline platelet count and NLR are associated with early but not late failure of iliocaval venous stents. This suggests different pathophysiologic mechanisms and a role for both platelet activation and inflammatory mechanisms in early rather than late stent thrombosis. Future research is needed to better explain this novel finding.

Original languageEnglish (US)
Pages (from-to)320-326
Number of pages7
JournalCirculation journal : official journal of the Japanese Circulation Society
Volume83
Issue number2
DOIs
StatePublished - Jan 25 2019

Fingerprint

Platelet Count
Stents
Neutrophils
Lymphocytes
Platelet Activation
Blood Platelets
Blood Cell Count
Angiography
Pathologic Constriction
Thrombosis
Inflammation

Keywords

  • Neutrophil/lymphocyte ratio
  • Platelet
  • Thrombosis
  • Venous stent

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{df06ff9d656949789a551c88bc5d780e,
title = "Early Venous Stent Failure Predicted by Platelet Count and Neutrophil/Lymphocyte Ratio",
abstract = "BACKGROUND: Inflammation and platelet activation have been shown to be involved in acute thromobogenicity following venous occlusive conditions. The aim of this study was to identify the association of baseline platelet count and neutrophil/lymphocyte ratio (NLR) with venous stent failure. Methods and Results: Patients who underwent technically successful iliocaval venous stent placement with available baseline complete blood count and follow-up stent patency data were selected (n=50). Stent failure was defined as >50{\%} stenosis or occlusion at follow-up angiography, contrast-enhanced CT, MRI or duplex US. Median patient age was 49.5 years (range, 13-76 years), and 62{\%} were female. Median follow-up time was 10.2 months (range, 0.1-76.4 months). Stent failure occurred in 13 patients (26{\%}) after a median of 1.2 months (range, 1 day-76.4 months). On multivariable-adjusted Cox modeling, baseline platelets (HR, 2.28; P=0.004) and WBC count (HR, 2.03; P=0.013) were significantly associated with stent failure on follow-up; neutrophils (HR, 16.10; P=0.050); and NLR (HR, 12.19; P=0.050) had borderline significance. Compared with patients without stent failure, those with early, but not late, stent failure had higher baseline platelets (P=0.031) and neutrophils (P=0.025), and NLR (P=0.026). CONCLUSIONS: Baseline platelet count and NLR are associated with early but not late failure of iliocaval venous stents. This suggests different pathophysiologic mechanisms and a role for both platelet activation and inflammatory mechanisms in early rather than late stent thrombosis. Future research is needed to better explain this novel finding.",
keywords = "Neutrophil/lymphocyte ratio, Platelet, Thrombosis, Venous stent",
author = "Younes Jahangiri and Masayuki Endo and Ramsey Al-Hakim and John Kaufman and Khashayar Farsad",
year = "2019",
month = "1",
day = "25",
doi = "10.1253/circj.CJ-18-0592",
language = "English (US)",
volume = "83",
pages = "320--326",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "2",

}

TY - JOUR

T1 - Early Venous Stent Failure Predicted by Platelet Count and Neutrophil/Lymphocyte Ratio

AU - Jahangiri, Younes

AU - Endo, Masayuki

AU - Al-Hakim, Ramsey

AU - Kaufman, John

AU - Farsad, Khashayar

PY - 2019/1/25

Y1 - 2019/1/25

N2 - BACKGROUND: Inflammation and platelet activation have been shown to be involved in acute thromobogenicity following venous occlusive conditions. The aim of this study was to identify the association of baseline platelet count and neutrophil/lymphocyte ratio (NLR) with venous stent failure. Methods and Results: Patients who underwent technically successful iliocaval venous stent placement with available baseline complete blood count and follow-up stent patency data were selected (n=50). Stent failure was defined as >50% stenosis or occlusion at follow-up angiography, contrast-enhanced CT, MRI or duplex US. Median patient age was 49.5 years (range, 13-76 years), and 62% were female. Median follow-up time was 10.2 months (range, 0.1-76.4 months). Stent failure occurred in 13 patients (26%) after a median of 1.2 months (range, 1 day-76.4 months). On multivariable-adjusted Cox modeling, baseline platelets (HR, 2.28; P=0.004) and WBC count (HR, 2.03; P=0.013) were significantly associated with stent failure on follow-up; neutrophils (HR, 16.10; P=0.050); and NLR (HR, 12.19; P=0.050) had borderline significance. Compared with patients without stent failure, those with early, but not late, stent failure had higher baseline platelets (P=0.031) and neutrophils (P=0.025), and NLR (P=0.026). CONCLUSIONS: Baseline platelet count and NLR are associated with early but not late failure of iliocaval venous stents. This suggests different pathophysiologic mechanisms and a role for both platelet activation and inflammatory mechanisms in early rather than late stent thrombosis. Future research is needed to better explain this novel finding.

AB - BACKGROUND: Inflammation and platelet activation have been shown to be involved in acute thromobogenicity following venous occlusive conditions. The aim of this study was to identify the association of baseline platelet count and neutrophil/lymphocyte ratio (NLR) with venous stent failure. Methods and Results: Patients who underwent technically successful iliocaval venous stent placement with available baseline complete blood count and follow-up stent patency data were selected (n=50). Stent failure was defined as >50% stenosis or occlusion at follow-up angiography, contrast-enhanced CT, MRI or duplex US. Median patient age was 49.5 years (range, 13-76 years), and 62% were female. Median follow-up time was 10.2 months (range, 0.1-76.4 months). Stent failure occurred in 13 patients (26%) after a median of 1.2 months (range, 1 day-76.4 months). On multivariable-adjusted Cox modeling, baseline platelets (HR, 2.28; P=0.004) and WBC count (HR, 2.03; P=0.013) were significantly associated with stent failure on follow-up; neutrophils (HR, 16.10; P=0.050); and NLR (HR, 12.19; P=0.050) had borderline significance. Compared with patients without stent failure, those with early, but not late, stent failure had higher baseline platelets (P=0.031) and neutrophils (P=0.025), and NLR (P=0.026). CONCLUSIONS: Baseline platelet count and NLR are associated with early but not late failure of iliocaval venous stents. This suggests different pathophysiologic mechanisms and a role for both platelet activation and inflammatory mechanisms in early rather than late stent thrombosis. Future research is needed to better explain this novel finding.

KW - Neutrophil/lymphocyte ratio

KW - Platelet

KW - Thrombosis

KW - Venous stent

UR - http://www.scopus.com/inward/record.url?scp=85060629081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060629081&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-18-0592

DO - 10.1253/circj.CJ-18-0592

M3 - Article

VL - 83

SP - 320

EP - 326

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 2

ER -